Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells
Author:
Affiliation:
1. Symphogen A/S; Lyngby; Denmark
2. Department of Haematology L4042; Rigshospitalet; Copenhagen
3. Department of Haematology; Vejle Sygehus; Vejle; Denmark
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12503/fullpdf
Reference50 articles.
1. Efficient expression from one CMV enhancer controlling two core promoters;Andersen;Molecular Biotechnology,2011
2. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5;Bikah;International Immunology,1998
3. Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co-mitogenic signalling;Calvo;Tissue Antigens,1999
4. Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study;Coiffier;Blood,2008
5. Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies;Dechant;Cancer Research,2008
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CD5 deletion enhances the antitumor activity of adoptive T cell therapies;Science Immunology;2024-07-19
2. Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity;Cell Reports Medicine;2024-07
3. Chimeric Antigen Receptor-Induced Antigen Loss Protects Cd5.Cart Cells from Fratricide Without Compromising On-Target Cytotoxicity;2023
4. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer;Frontiers in Genetics;2022-09-29
5. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities;Acta Neuropathologica;2022-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3